## Abstract ## Purpose To investigate the eligibility of diffusion‐weighted imaging (DWI) for the evaluation of tumor cellularity in patients with soft‐tissue sarcomas. ## Materials and Methods Thirty consecutive patients with a total of 31 histologically‐proven soft‐tissue sarcomas prospectivel
Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma
✍ Scribed by H. C. Holscher; H. -J. Woude; J. Hermans; M. A. Nooy; J. Doornbos; J. L. Bloem
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 484 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0364-2348
No coin nor oath required. For personal study only.
✦ Synopsis
To study the effect of chemotherapy on normal fat, skeletal muscle, and bone marrow, T1 and T2 relaxation times were measured in 15 patients with bone sarcoma before and after each cycle of preoperative chemotherapy. A section plane containing the tumor and if possible the nonaffected extremity was imaged with combined multiecho spin echo and inversion recovery pulse sequences. T1 and T2 relaxation times were calculated in the normal-appearing tissues. Although some variation was found in the values in the individual patient and between patients, no systematic changes of relaxation times of fat, muscle, or bone marrow occurred in the course of treatment. We conclude that the chemotherapy used in bone sarcoma has no effect on relaxation times of normal fat, muscle, and bone marrow, and that therefore these tissues may serve as a reference for the signal intensity of tumor.
📜 SIMILAR VOLUMES
## Abstract Restriction fragment length polymorphisms (RFLPs) of 2 oncogenes, c‐Ha‐__ras__ and L‐__myc__, have been analyzed in 101 patients with bone and soft‐tissue sarcoma and in 98 normal individuals. The c‐Ha‐__ras__ gene was highly polymorphic both in sarcoma patients and in normal individual
## Abstract ## BACKGROUND. For patients with advanced soft tissue sarcoma (STS), no standard treatment is established after previous chemotherapy with anthracyclines and ifosfamide. Bendamustine hydrochloride is a bifunctional alkylating agent that is not cross‐resistant to other DNA‐interacting s